The evidence cited includes the patent's listing in the FDA Orange Book, public statements by Hims's CEO on an August 2024 investor call discussing GLP-1 patent cliffs and acknowledging that semaglutide was not going off patent, and a formal demand letter sent by Novo Nordisk on February 8, 2026, one day before filing
No prescription needed: Compounded semaglutide always requires a prescription
Doctor Consultations: You always have access to your assigned WeightCare physician at any point in your health journey with WeightCare
Some patients also experience vomiting, particularly when first starting the medication or after dose increases
Clinical Trials for Weight Loss Drugs Clinical trials are an important part of the process by which new drugs become available
One consistently outperforms the other in head-to-head clinical trials, and the right choice depends on your weight loss goals, your health history, and your budget